Teladoc Health Sees Unusually Large Options Volume (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) saw unusually large options trading activity on Tuesday. Stock investors purchased 22,980 call options on the stock. This represents an increase of 69% compared to the typical volume of 13,593 call options.

Analyst Ratings Changes

TDOC has been the topic of several analyst reports. The Goldman Sachs Group assumed coverage on Teladoc Health in a research report on Friday, November 15th. They issued a “buy” rating and a $14.00 price objective on the stock. Piper Sandler reissued an “overweight” rating and set a $13.00 price objective (up from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Royal Bank of Canada raised their price target on Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 9th. Evercore ISI increased their price objective on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Fourteen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $12.24.

Insider Buying and Selling

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares in the company, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.95% of the stock is owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently added to or reduced their stakes in TDOC. Point72 Asset Management L.P. lifted its stake in shares of Teladoc Health by 57.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock valued at $76,803,000 after purchasing an additional 3,063,172 shares during the last quarter. Rubric Capital Management LP bought a new stake in Teladoc Health in the second quarter worth $45,267,000. Clearline Capital LP boosted its stake in Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after buying an additional 3,483,665 shares during the period. Geode Capital Management LLC increased its position in Teladoc Health by 1.5% during the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after acquiring an additional 56,864 shares during the last quarter. Finally, Assenagon Asset Management S.A. bought a new position in Teladoc Health during the third quarter valued at $15,801,000. 76.82% of the stock is owned by institutional investors.

Teladoc Health Trading Up 0.5 %

Shares of TDOC opened at $9.98 on Wednesday. The stock has a market capitalization of $1.72 billion, a PE ratio of -1.73 and a beta of 1.01. The company’s fifty day moving average is $9.92 and its 200 day moving average is $9.03. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $22.16.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The firm had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Sell-side analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.